In Amyotrophic Lateral Sclerosis (ALS) spinal cord (SC) showed a moderate increase in FDG uptake with respect to healthy subjects. The main aim of our study is to integrate the information concerning the divergent behavior of SC with skeletal muscle metabolism improving the informative potential of 18F-fluoro-2-deoxy-glucose (FDG) PET/CT...
-
2020 (v1)PublicationUploaded on: April 14, 2023
-
2016 (v1)Publication
Genetic discoveries in amyotrophic lateral sclerosis (ALS) have a significant impact on deciphering molecular mechanisms of motor neuron degeneration but, despite recent advances, the etiology of most sporadic cases remains elusive. Several cellular mechanisms contribute to the motor neuron degeneration in ALS, including RNA metabolism,...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
PURPOSE: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease leading to neuromuscular palsy and death. We propose a computational approach to [18F]-fluorodeoxyglucose (FDG) PET/CT images to analyze the structure and metabolic pattern of skeletal muscle in ALS and its relationship with disease aggressiveness. MATERIALS AND...
Uploaded on: March 27, 2023 -
2018 (v1)Publication
We recently reported the potential of Hough transform in delineating spinal cord metabolism by 18F-fluorodeoxyglucose PET/CT scanning in amyotrophic lateral sclerosis. The present study aimed to verify the relationship between spinal cord and brain metabolism in 44 prospectively recruited patients affected by amyotrophic lateral sclerosis...
Uploaded on: March 27, 2023 -
2019 (v1)Publication
Amyotrophic lateral sclerosis (ALS) is characterized by a spectrum of phenotypes, but only a few studies have addressed the presence of parkinsonian (PK) symptoms. The aim of our study was to investigate the occurrence of PK features in a prospective population-based cohort of ALS patients, determining their demographic, clinical,...
Uploaded on: April 14, 2023